WESTPORT, Conn., Sept. 16, 2014 /PRNewswire/ -- HemCon
Medical Technologies, Inc. ("HemCon"), a wholly owned subsidiary of
TriStar Wellness Solutions(R), Inc. (OTCQB: TWSI) and a leading
developer and marketer of advanced medical products, announced
today that the revenue performance on their chitosan technology
platform has grown by 39 percent, and microdispersed oxidized
cellulose raw material is up 22 percent year-to-date though August
2014. Overall, TWSI expects third quarter revenues to surpass
the prior year in excess of 50 percent and be in line with overall
business expectations for 2014.
Photo - http://photos.prnewswire.com/prnh/20140915/146136
Photo - http://photos.prnewswire.com/prnh/20140915/146137
The company has continued organic growth in the domestic market
has seen strong momentum coming from international markets in 2014
and expects this growth pattern to continue with impending
regulatory registration approvals for China and India.
The U.S. domestic market growth is fueled by best-in-class
products, which are efficacious, support positive patient outcomes
and drive value and cost savings back into healthcare.
Primary among these is the HemCon Patch® PRO used for
diagnostic and interventional cardiac catheterization to stop
bleeding from the catheter access point in 10-15 minutes. This
product is highly regarded and used in leading hospitals and
facilities across the country.
Surgical market acceptance for GuardaCare®XR
Surgical, HemCon's latest innovation for surgical wounds and
traumatic injuries, has increased. The product allows for fast
hemostasis and maintenance of a clear field of vision during
various surgical procedures where control of bleeding is of
critical importance. The product has gained significant market
acceptance in 2014 as a result of the effort of HemCon's direct and
independent sales force.
The HemCon dental product line has grown by 33 percent in the
U.S. and 2014 saw the launch of the online ordering platform
www.hemcondental.com which simplifies the supply chain for oral and
maxillofacial surgeons, periodontists and dentists looking for an
ideal practice management tool, allowing for quick patient turns
and wound protection following oral procedures.
Military sales have grown 30 percent year-on-year. Though this
business remains very unpredictable, we have seen a positive upward
trend. HemCon's ChitoGauze® PRO was recently added to
the CoTCCC (Committee on Tactical Combat Casualty Care) guidelines
for recommended hemostats of choices on the battlefield, providing
continued support to U.S. Troops and those of Allied Forces across
the globe.
"With continued focus on innovation, HemCon will have a number
of new products enter the market in 2015 and beyond, adding to our
efforts of sustained growth," said Michael
Wax, President and CEO of HemCon. "I am encouraged by
HemCon's success to date and look forward to the bright future
ahead."
About HemCon Medical Technologies
HemCon Medical Technologies Inc., founded in 2001, develops,
manufactures and markets innovative technologies for hemostatic
devices for the control of bleeding resulting from trauma or
surgery. HemCon products are designed for use by medical
professionals in hospital and clinical settings, military and
civilian first responders, as well as where control of bleeding is
of critical importance. New product development is directed at
novel wound care treatment solutions as well as enhancing
hemostasis. HemCon is headquartered in Portland, Oregon. For more information, please
visit www.hemcon.com.
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (TWSI) is a health and
wellness company that targets under-met consumer opportunities in
the OTC and professional marketplace. Its core strategy plans to
meet the growing demand for personalized, care solutions by
leveraging proprietary innovation and healthcare technology with
the rapid transformation of the healthcare marketplace to create
innovative, science-based solutions and brands. TriStar recently
acquired HemCon Medical Technologies Inc., a developer,
manufacturer and marketer of innovative technologies for hemostatic
devices for the control of bleeding resulting from trauma or
surgery. It also owns the Beaute de Maman™ brand of
women's health products. Additional information is available at
www.tstarwellness.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc.
contains forward-looking statements. Generally, you can identify
these statements because they use words like "anticipates,"
"believes," "expects," "future," "intends," "plans" and similar
terms. These statements reflect only our current expectations.
Although we do not make forward-looking statements unless we
believe we have a reasonable basis for doing so, we cannot
guarantee their accuracy and actual results may differ materially
from those we anticipated due to a number of uncertainties, many of
which are unforeseen, including, among others, the risks we face as
described our filings with the Securities and Exchange Commission.
You should not place undue reliance on these forward-looking
statements, which apply only as of the date of this press release.
To the extent that such statements are not recitations of
historical fact, such statements constitute forward-looking
statements that, by definition, involve risks and uncertainties. In
any forward-looking statement where we express an expectation or
belief as to future results or events, such expectation or belief
is expressed in good faith and believed to have a reasonable basis,
but there can be no assurance that the statement of expectation of
belief will be accomplished.
Contact:
Simona
Buergi
Tel: (503) 245-0459
Email
Web site: http://www.tstarwellness.com
SOURCE TriStar Wellness Solutions, Inc.